课题基金 / 基金详情

项目摘要

项目成果

L. David Sibley的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT Cryptosporidiosis is an important cause of diarrheal disease in young children in the developing world where it causes significant mortality and morbidity. Children that present with symptomatic disease are more likely to suffer from malnutrition and lower height and weight per age, and these deficiencies persist for years after the primary infection resolves. Surprisingly even asymptomatic cases can be associated with malnutrition and failure to thrive for several years beyond the initial infection. These findings suggest that alterations in intestinal function during the initial infection establish persistent enteropathy that stunts development. However, the cellular and molecular mechanisms driving this clinical outcome remain unresolved. During early development of the intestine, Goblet cells play a critical role in sampling of antigens from the gut lumen in a process that generates peripheral T regulatory cells (pTreg), which suppress immune responses to dietary antigens and commensals. This early process in shaping the mucosal immune system is critical to maintenance of oral tolerance later in life. Our study examines the intriguing hypothesis that cryptosporidiosis in early life alters responses to lumenal antigens by disrupting oral tolerance that normally develops during this time period. In preliminary studies we have shown that neonatal mice, which are highly susceptible to C. parvum infection, show defects in Goblet cell functions related to antigenic sampling. Furthermore we show that C. parvum infected neonatal mice have reduced development of pTreg cells. We will explore the hypothesis that cryptosporidiosis disrupts oral tolerance through two main aims: 1) determine the molecular mechanism for disruption of antigen sampling by Goblet cells, 2) explore the consequence of disrupted pTreg development on oral tolerance. These studies will explore how altered immune responses to dietary antigens or commensal organisms drive inflammation that impairs gut function following enteric infection.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Regulation of host cell egress by Toxoplasma gondii
  • 批准号:
    10640220
  • 项目类别:
  • 资助金额:
    $61.44万
  • 财政年份:
    2022
  • 负责人:
    L. David Sibley
  • 依托单位:
Regulation of host cell egress by Toxoplasma gondii
  • 批准号:
    10441782
  • 项目类别:
  • 资助金额:
    $62.16万
  • 财政年份:
    2022
  • 负责人:
    L. David Sibley
  • 依托单位:
Reactivation of Chronic Toxoplasmosis
  • 批准号:
    10239417
  • 项目类别:
  • 资助金额:
    $24.82万
  • 财政年份:
    2021
  • 负责人:
    L. David Sibley
  • 依托单位:
Interferon-mediated control mechanisms in human cells
  • 批准号:
    10041166
  • 项目类别:
  • 资助金额:
    $23.63万
  • 财政年份:
    2020
  • 负责人:
    L. David Sibley
  • 依托单位:
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: